Skip to main content

Table 2 Meta-analyses results of the current study

From: Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysis

Variables

Sample size

Dominant comparison

Recessive comparison

Over-dominant comparison

Allele comparison

P value OR (95%CI) I2 statistic

 

P value

OR (95%CI) I2 statistic

P value OR (95% CI) I2 statistic

 

P value

OR (95%CI) I2 statistic

VDR rs7975232

 Overall

668/894

0.03

60%

1.58 (1.04–2.39)

0.42

31%

0.90 (0.69–1.17)

0.03

44%

0.80 (0.65–0.98)

0.09

76%

1.41 (0.94–2.12)

 East Asian

528/632

0.02

40%

1.39 (1.06–1.81)

0.40

0%

0.88 (0.67–1.17)

0.28

62%

0.75 (0.45–1.26)

0.17

55%

1.30 (0.89–1.89)

VDR rs1544410

 Overall

668/894

0.26

44%

1.15 (0.90–1.45)

0.62

8%

0.93 (0.71–1.22)

0.54

0%

0.93 (0.75–1.16)

0.30

50%

1.09 (0.93–1.27)

 East Asian

528/632

0.98

0%

1.00 (0.74–1.34)

0.91

0%

0.98 (0.75–1.30)

0.90

0%

1.02 (0.79–1.30)

0.96

0%

1.00 (0.83–1.19)

VDR rs2228570

 Overall

805/1088

< 0.0001

46%

1.54 (1.25–1.89)

0.0004

19%

0.67 (0.54–0.84)

0.58

0%

0.95 (0.79–1.14)

0.01

59%

1.34 (1.06–1.68)

 East Asian

725/928

< 0.0001

45%

1.63 (1.31–2.04)

0.0003

40%

0.66 (0.53–0.83)

0.58

0%

0.95 (0.78–1.15)

0.01

65%

1.40 (1.08–1.82)

VDR rs731236

 Overall

668/894

0.06

43%

1.25 (0.99–1.58)

0.26

0%

0.86 (0.66–1.12)

0.42

38%

0.92 (0.74–1.14)

0.06

42%

1.16 (0.99–1.36)

 East Asian

528/632

0.44

57%

1.34 (0.64–2.82)

0.51

0%

0.91 (0.68–1.21)

0.54

66%

0.77 (0.33–1.78)

0.39

55%

1.08 (0.91–1.29)

VEGF rs699947

 Overall

739/886

0.92

54%

1.02 (0.69–1.52)

0.04

0%

0.63 (0.41–0.98)

0.61

45%

0.95 (0.77–1.17)

0.61

51%

1.08 (0.80–1.46)

 East Asian

713/785

0.84

64%

1.05 (0.66–1.66)

0.10

0%

0.67 (0.41–1.08)

0.70

56%

1.08 (0.72–1.65)

0.99

59%

1.00 (0.70–1.42)

VEGF rs1570360

 Overall

293/336

0.12

37%

1.31 (0.93–1.85)

0.57

19%

0.75 (0.29–1.98)

0.17

7%

0.78 (0.55–1.11)

0.13

49%

1.26 (0.94–1.70)

 East Asian

191/209

0.28

60%

1.49 (0.72–3.06)

0.24

0%

0.27 (0.03–2.41)

0.15

44%

0.71 (0.45–1.13)

0.28

64%

1.46 (0.73–2.91)

VEGF rs2010963

 Overall

715/871

0.79

55%

1.05 (0.72–1.54)

0.26

0%

1.17 (0.89–1.55)

0.80

48%

0.97 (0.80–1.19)

0.32

13%

0.93 (0.81–1.07)

 East Asian

715/871

0.79

55%

1.05 (0.72–1.54)

0.26

0%

1.17 (0.89–1.55)

0.80

48%

0.97 (0.80–1.19)

0.32

13%

0.93 (0.81–1.07)

VEGF rs3025039

 Overall

994/970

0.08

12%

1.20 (0.98–1.48)

0.08

38%

0.50 (0.23–1.09)

0.21

0%

0.87 (0.71–1.08)

0.05

28%

1.21 (1.00–1.46)

 East Asian

568/625

0.10

0%

1.24 (0.96–1.59)

0.87

69%

0.83 (0.09–7.41)

0.25

0%

0.86 (0.66–1.11)

0.06

34%

1.24 (0.99–1.56)

IL-18 rs187238

 Overall

1653/2594

0.38

85%

1.19 (0.81–1.77)

0.50

16%

1.14 (0.78–1.66)

0.26

88%

0.77 (0.49–1.21)

0.56

78%

1.09 (0.82–1.43)

 East Asian

1180/2022

0.62

81%

1.11 (0.73–1.70)

0.27

33%

1.33 (0.80–2.22)

0.49

81%

0.86 (0.55–1.34)

0.76

78%

1.06 (0.74–1.50)

 South Asian

361/370

0.60

97%

1.70 (0.24–12.29)

0.65

0%

1.19 (0.57–2.47)

0.53

98%

0.45 (0.04–5.35)

0.69

92%

1.25 (0.42–3.66)

 HBV

881/1443

0.90

78%

1.03 (0.65–1.63)

0.23

43%

1.38 (0.81–2.33)

0.73

78%

0.92 (0.57–1.48)

0.96

74%

1.01 (0.70–1.46)

IL18 rs1946518

 Overall

1599/2045

0.002

0%

0.79 (0.68–0.92)

0.004

30%

1.26 (1.08–1.48)

0.75

0%

1.02 (0.90–1.17)

0.002

59%

0.78 (0.67–0.91)

 East Asian

1126/1464

0.09

0%

0.86 (0.71–1.02)

0.15

0%

1.14 (0.95–1.37)

0.79

0%

1.02 (0.87–1.19)

0.04

68%

0.80 (0.65–0.99)

 South Asian

589/679

0.001

0%

0.66 (0.51–0.85)

0.02

0%

1.57 (1.09–2.27)

0.98

54%

0.99 (0.61–1.61)

0.002

0%

0.72 (0.59–0.89)

 HBV

827/885

0.01

9%

0.77 (0.62–0.95

0.06

21%

1.25 (0.99–1.57)

0.52

0%

1.06 (0.88–1.29)

0.03

73%

0.73 (0.55–0.96)

MBL rs7096206

 Overall

931/821

< 0.0001 0.59 (0.48–0.73) 0%

 

0.37

70%

1.81 (0.50–6.59)

< 0.0001

0%

1.59 (1.28–1.97)

< 0.0001 0%

0.63 (0.53–0.76)

 East Asian

869/706

< 0.0001

0%

0.62 (0.50–0.78)

0.35

79%

2.08 (0.44–9.80)

0.0005

0%

1.50 (1.19–1.88)

< 0.0001 4%

0.65 (0.53–0.79)

MBL rs1800450

 Overall

857/650

0.85

79%

0.95 (0.58–1.55)

0.91

77%

1.06 (0.37–3.06)

0.70

75%

1.10 (0.69–1.74)

0.95

80%

0.99 (0.65–1.50)

 East Asian

642/486

0.99

90%

0.99 (0.44–2.23)

0.61

81%

1.47 (0.34–6.30)

0.99

86%

1.00 (0.49–2.03)

0.95

90%

0.98 (0.48–1.99)

  1. Abbreviations: OR odds ratio, CI confidence interval, NA not available, HBV hepatitis B virus infection
  2. The values in italics represent that there is statistically significant differences between cases and controls